Riskpilot← Back to searchSign inGet full accessCebreo Medical A/S
A/SActiveCVR 36965002Borupvang 2Manufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 201532 employeestweng.com
Revenue 2025
DKK -18,6M
-13% vs 2024
EBITDA margin
235.9%
+6% vs 2024
Equity ratio
-1489.1%
Financial strength
Net profit 2025
DKK -70,3M
-91% vs 2024
| Revenue | DKK -18,6M | -13% |
| EBITDA | DKK -43,8M | +6% |
| Net profit | DKK -70,3M | -91% |
| Total assets | DKK 6,2M | -81% |
| Equity | DKK -92,7M | -315% |
| Employees | 32 | — |
Legal name
Cebreo Medical A/S
CVR number
36965002
Legal form
Aktieselskab
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
15. juli 2015
Share capital
DKK 500.000
Employees
32 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem i forening med en direktør.
Company purpose
Selskabets formål er at udvikle, producere og kommercialisere medicinsk udstyr, software og serviceydelser samt al hermed beslægtet virksomhed.
Address
Borupvang 2
Phone
+4540638000
Email
info@tweng.com
Website
tweng.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -3.114 | -6.121 | -2.669 | -3.814 | -1.630 | -7.990 | -8.334 | -20.456 | -21.339 | -18.551 |
| Staff expenses | -5.650 | -12.423 | -8.292 | -13.812 | -5.729 | -10.723 | -15.020 | -20.918 | -24.966 | -25.202 |
| EBITDA | -8.765 | -18.545 | -10.961 | -17.626 | -7.359 | -18.713 | -23.354 | -41.374 | -46.305 | -43.753 |
| Depreciation & amort. | -4.080 | -6.994 | -7.025 | -2.256 | -7.241 | -301 | -485 | -475 | -459 | -230 |
| EBIT | -12.844 | -25.539 | -17.986 | -19.882 | -14.600 | -19.014 | -23.839 | -41.849 | -46.764 | -43.983 |
| Net financials | -699 | -406 | -382 | -809 | 211 | 243 | -539 | -717 | -1.259 | -2.925 |
| Profit before tax | -13.543 | -25.944 | -18.368 | -20.691 | -14.389 | -18.771 | -24.378 | -42.566 | -48.023 | -46.908 |
| Tax | -2.979 | -5.638 | -4.040 | -4.669 | -3.368 | -4.337 | -5.928 | -10.013 | -11.223 | 23.438 |
| Net profit | -10.564 | -20.307 | -14.328 | -16.022 | -11.021 | -14.434 | -18.450 | -32.553 | -36.800 | -70.346 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 42.286 | 33.036 | 41.859 | 75.214 | 25.615 | 14.374 | 18.951 | 23.623 | 33.497 | 6.223 |
| Equity | -10.064 | 19.629 | 30.299 | 14.277 | 3.256 | -9.278 | 14.403 | 14.481 | -22.319 | -92.665 |
| Long-term debt | 0 | 0 | 0 | 0 | 12.934 | 1.886 | 1.194 | 775 | 47.492 | 90.327 |
| Short-term debt | 45.569 | 8.158 | 4.592 | 59.360 | 9.383 | 21.766 | 3.354 | 8.367 | 8.324 | 8.561 |
| Total debt | 45.569 | 8.158 | 4.592 | 59.360 | 22.317 | 23.652 | 4.548 | 9.142 | 55.816 | 98.888 |
EBITDA margin
-4375300000.0%
This company
15.8%
Market median
-27691772252% vs market
20162025
Equity ratio
-1489.1%
This company
38.2%
Market median
-3998% vs market
20162025
Return on equity
-7034600000.0%
This company
18.4%
Market median
-38231521839% vs market
20162025
Net profit margin
-7034600000.0%
This company
8.1%
Market median
-86846913680% vs market
20162025
Asset turnover
-2.98×
This company
1.12×
Market median
-366% vs market
20162025
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20162025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-15 – 2016-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RT Management | Management | 2024 | — | — |
RE Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
T&W Medical A/S | Company | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
T&W Medical A/S
Cebreo Medical A/S Board members of Cebreo Medical A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Richard Tøpholm | Management | 0 companies |
| Rasmus Elsborg Madsen | Chief Executive Officer | 0 companies |
| Jan Tøpholm | Board of Directors | 0 companies |
| Julian Tøpholm | Chairman | 0 companies |
| Søren Erik Westermann | Board of Directors | 0 companies |
| Adam Westermann | Board of Directors | 0 companies |
| Henrik Skak Bender | Board of Directors | 0 companies |
| Lars Nørgaard | Board of Directors | 0 companies |
| Lene Ploug Bülow | Board of Directors | 0 companies |